Table 3:
Impact of time difference between liver biopsy and VCTE on performance of VCTE.
| Predictor | Outcome | AUROC | P-value from test of independence of AUROC | |
|---|---|---|---|---|
| VCTE and biopsy within 30 days (N=38) | VCTE and biopsy more than 30 days (N=61) | |||
| STEATOSIS GRADE | ||||
| CAP | 0 vs. 1–3 | 0.89 (0.78, 1.0) | 0.85 (0.74, 0.95) | 0.5697 |
| 0–1 vs. 2–3 | 0.92 (0.82, 1.0) | 0.96 (0.91, 1.0) | 0.4667 | |
| 0–2 vs. 3 | 0.77 (0.63, 0.91) | 0.95 (0.90, 1.0) | 0.0174 | |
| FIBROSIS STAGE | ||||
| LSM | 0 vs. 1–4 | 0.77 (0.61, 0.92) | 0.86 (0.76, 0.95) | 0.3447 |
| 0–1 vs. 2–4 | 0.82 (0.59, 1.0) | 0.92 (0.84, 1.0) | 0.3882 | |
| 0–2 vs. 3–4 | 0.96 (0.90, 1.0) | 0.97 (0.92, 1.0) | 0.8326 | |
| 0–3 vs. 4 | 0.99 (0.97, 1.0) | 0.96 (0.91, 1.0) | 0.2270 | |